Omeros Corporation
NASDAQ: OMER0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gregory A. Demopulos
- Employees
- 202
- Headquarters
- Seattle, United States
- IPO year
- 2009
- Market cap
- $765.7M
- Website
- https://www.omeros.com
Loading OMER…
Loading profile data…Frequently asked questions about OMER
What does Omeros Corporation (OMER) do?
Omeros Corporation is a biopharmaceutical firm with commercialized products, actively engaged in the discovery, development, and market introduction of both small-molecule and protein-based therapies, including treatments for rare diseases. The company's therapeutic endeavors primarily focus on inflammatory conditions, illnesses mediated by the...
Where does OMER trade?
Omeros Corporation (OMER) trades on the NASDAQ Global Market.
What sector is OMER in?
Omeros Corporation (OMER) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Omeros Corporation?
Gregory A. Demopulos is the chief executive officer of Omeros Corporation (OMER).
Where is Omeros Corporation headquartered?
Omeros Corporation is headquartered in United States.
Does OMER pay a dividend?
Omeros Corporation (OMER) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OMER go public?
Omeros Corporation (OMER) completed its initial public offering in 2009.